XASEINFU
Market cap174mUSD
Dec 24, Last price
8.21USD
1D
0.74%
1Q
37.75%
Jan 2017
221.96%
IPO
52.04%
Name
InfuSystem Holdings Inc
Chart & Performance
Profile
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 125,785 14.44% | 109,914 7.36% | 102,382 5.13% | |||||||
Cost of revenue | 120,707 | 105,679 | 95,223 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 5,078 | 4,235 | 7,159 | |||||||
NOPBT Margin | 4.04% | 3.85% | 6.99% | |||||||
Operating Taxes | 979 | 112 | (163) | |||||||
Tax Rate | 19.28% | 2.64% | ||||||||
NOPAT | 4,099 | 4,123 | 7,322 | |||||||
Net income | 872 4,744.44% | 18 -98.73% | 1,420 -91.81% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (1,311) | (5,297) | (608) | |||||||
BB yield | 0.57% | 2.83% | 0.16% | |||||||
Debt | ||||||||||
Debt current | 1,474 | 931 | 349 | |||||||
Long-term debt | 40,699 | 40,679 | 40,088 | |||||||
Deferred revenue | 27,496 | 28,346 | ||||||||
Other long-term liabilities | (33,157) | (32,748) | ||||||||
Net debt | 41,942 | (2,760) | (1,717) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 11,223 | 17,517 | 18,316 | |||||||
CAPEX | (1,024) | (15,076) | (16,656) | |||||||
Cash from investing activities | (6,734) | (11,478) | (21,315) | |||||||
Cash from financing activities | (4,423) | (6,060) | (6,463) | |||||||
FCF | 36,006 | 3,009 | 272 | |||||||
Balance | ||||||||||
Cash | 231 | 165 | 186 | |||||||
Long term investments | 44,205 | 41,968 | ||||||||
Excess cash | 38,874 | 37,035 | ||||||||
Stockholders' equity | (57,535) | (57,853) | (53,633) | |||||||
Invested Capital | 146,211 | 138,044 | 134,270 | |||||||
ROIC | 2.88% | 3.03% | 5.60% | |||||||
ROCE | 5.73% | 4.93% | 8.42% | |||||||
EV | ||||||||||
Common stock shares outstanding | 21,646 | 21,547 | 22,050 | |||||||
Price | 10.54 21.43% | 8.68 -49.03% | 17.03 -9.32% | |||||||
Market cap | 228,150 21.99% | 187,031 -50.19% | 375,506 -7.93% | |||||||
EV | 270,092 | 184,271 | 373,789 | |||||||
EBITDA | 17,586 | 17,595 | 21,784 | |||||||
EV/EBITDA | 15.36 | 10.47 | 17.16 | |||||||
Interest | 2,170 | 1,402 | 1,377 | |||||||
Interest/NOPBT | 42.73% | 33.11% | 19.23% |